BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34809976)

  • 1. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
    Carbajo-García MC; García-Alcázar Z; Corachán A; Monleón J; Trelis A; Faus A; Pellicer A; Ferrero H
    Fertil Steril; 2022 Feb; 117(2):433-443. PubMed ID: 34809976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas.
    Carbajo-García MC; Corachán A; Segura-Benitez M; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
    Reprod Biol Endocrinol; 2021 Jul; 19(1):106. PubMed ID: 34233687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
    Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
    Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
    Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
    Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
    Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
    Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance.
    Fujimoto T; Inoue-Mochita M; Iraha S; Tanihara H; Inoue T
    J Biol Chem; 2021 Sep; 297(3):101070. PubMed ID: 34389355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
    Levy G; Malik M; Britten J; Gilden M; Segars J; Catherino WH
    Fertil Steril; 2014 Jul; 102(1):272-281.e2. PubMed ID: 24825427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
    Lewis TD; Malik M; Britten J; Parikh T; Cox J; Catherino WH
    Fertil Steril; 2019 Apr; 111(4):806-815.e1. PubMed ID: 30871768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
    Joseph DS; Malik M; Nurudeen S; Catherino WH
    Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.
    Norian JM; Malik M; Parker CY; Joseph D; Leppert PC; Segars JH; Catherino WH
    Reprod Sci; 2009 Dec; 16(12):1153-64. PubMed ID: 19700613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.
    Chuang TD; Khorram O
    Fertil Steril; 2019 Dec; 112(6):1180-1189. PubMed ID: 31843095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
    Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
    Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.
    Jin JS; Tsao TY; Sun PC; Yu CP; Tzao C
    Pathol Oncol Res; 2012 Jul; 18(3):713-20. PubMed ID: 22270866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of TGF-β signaling on regulating proliferation of uterine leiomyoma cell via ERα signaling activated by bisphenol A, octylphenol and nonylphenol
    Shen Y; Lu Q; Zhang P; Wu Y; Ren M
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S276-S281. PubMed ID: 29970676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
    Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early growth response-2 expression in uterine leiomyoma cells: regulation and function.
    Yin P; Navarro A; Fang F; Xie A; Coon JS; Richardson C; Bulun SE
    Fertil Steril; 2011 Aug; 96(2):439-44. PubMed ID: 21703609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.